Evolve Private Wealth LLC Makes New Investment in Encompass Health Corporation $EHC

Evolve Private Wealth LLC acquired a new position in shares of Encompass Health Corporation (NYSE:EHC) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 8,781 shares of the company’s stock, valued at approximately $888,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. EP Wealth Advisors LLC increased its holdings in Encompass Health by 2.4% in the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after buying an additional 88 shares during the last quarter. Gamco Investors INC. ET AL lifted its holdings in Encompass Health by 2.0% during the 1st quarter. Gamco Investors INC. ET AL now owns 4,813 shares of the company’s stock worth $466,000 after buying an additional 94 shares during the last quarter. Gibson Capital LLC boosted its position in shares of Encompass Health by 4.3% during the 1st quarter. Gibson Capital LLC now owns 2,431 shares of the company’s stock worth $235,000 after acquiring an additional 101 shares in the last quarter. Leuthold Group LLC increased its holdings in shares of Encompass Health by 0.3% in the 4th quarter. Leuthold Group LLC now owns 31,168 shares of the company’s stock valued at $3,308,000 after acquiring an additional 104 shares during the last quarter. Finally, Covestor Ltd increased its holdings in shares of Encompass Health by 24.4% in the 4th quarter. Covestor Ltd now owns 540 shares of the company’s stock valued at $57,000 after acquiring an additional 106 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Barclays upped their price target on Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. UBS Group boosted their price objective on shares of Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Truist Financial upped their target price on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, August 7th. Leerink Partners set a $152.00 target price on shares of Encompass Health in a research report on Friday, May 22nd. Finally, Weiss Ratings upgraded shares of Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $148.71.

Encompass Health Price Performance

Shares of NYSE EHC opened at $120.24 on Monday. The stock has a market cap of $11.86 billion, a P/E ratio of 19.58, a P/E/G ratio of 2.43 and a beta of 0.72. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The stock has a 50 day moving average of $111.01 and a two-hundred day moving average of $106.47. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.48 by $0.07. The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period last year, the firm posted $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, research analysts forecast that Encompass Health Corporation will post 6.09 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a $0.21 dividend. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Thursday, October 1st. Encompass Health’s dividend payout ratio (DPR) is presently 12.38%.

Insiders Place Their Bets

In related news, CEO Mark J. Tarr sold 173,148 shares of the business’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the transaction, the chief executive officer owned 267,814 shares in the company, valued at $33,602,622.58. The trade was a 39.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP John Patrick Darby sold 8,906 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the sale, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.80% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.